TNGX compared with IMVT: revenue, margins and what each company keeps, and the suppliers and customers both name

TNGXTango Therapeutics, Inc.

Mkt capRevenueRevenue

IMVTImmunovant, Inc.

Mkt capRevenueRevenue

Compare

TNGXTango Therapeutics, Inc.

IMVTImmunovant, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Co-movers

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Co-movers

daily closes · 499dMethod ›

Moved together

TNGXwithIMVT

×0.14co-movement · IMVT on TNGX · 499d

r 0.27scale to r 0.75

Shared co-movers4with TNGXwith IMVT

IDYAIDEAYA Biosciences, Inc.r 0.33r 0.49

CLDXCelldex Therapeutics, Inc.r 0.29r 0.44

KURAKura Oncology, Inc.r 0.28r 0.46

NRIXNurix Therapeutics, Inc.r 0.28r 0.47

TNGX, solidIMVT, hatched× = co-movement · βr = correlationBar = r to r 0.75Order: weaker of A and BSource: daily closes

TNGXTango Therapeutics, Inc.

21.75▼−4.25%· post 21.75· delayed

Mkt cap$3.8BRevenue$54MQ3 FY25Revenue$42MFY24

IMVTImmunovant, Inc.

28.41▼−2.60%· post 28.41· delayed

After hoursNov 2 '26delayed

Mkt cap$6.0BRevenue—Revenue—

Compare

After hoursNov 2 '26delayed

TNGXTango Therapeutics, Inc.

IMVTImmunovant, Inc.

21.75▼−4.25%post 21.75delayed

Price

28.41▼−2.60%post 28.41delayed

$3.8B

Mkt cap

$6.0B

Q3 FY25$54M

Revenue

—

FY24$42M

Revenue

—

TNGX21.75▼−4.25%vsIMVT28.41▼−2.60%After hoursNov 2 '26delayed